Dioscorea extract (DA-9801) modulates markers of peripheral neuropathy in type 2 diabetic db/db mice

Biomolecules and Therapeutics

Volumn 22, Issue 5, 2014, Pages 445-452

  Moon, Eunjung ^a   Lee, Sung Ok ^b   Kang, Tong Ho ^c   Kim, Hye Ju ^d   Choi, Sang Zin ^d   Son, Mi Won ^d   Kim, Sun Yeou ^a  

^a Gachon University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Dong A Pharm Research Center   (South Korea)

Author keywords

DA 9801; Diabetic peripheral neuropathy; Dioscorea japonica Thunb; Dioscorea nipponica Makino; Nerve growth factor; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; DA 9801; DIOSCOREA JAPONICA EXTRACT; DIOSCOREA NIPPONICA EXTRACT; GLUCOSE; MESSENGER RNA; NERVE GROWTH FACTOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIOSCOREA JAPONICA; DIOSCOREA NIPPONICA; DRUG EFFECT; DRUG MECHANISM; GENE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HOT PLATE TEST; IN VITRO STUDY; KLF10 GENE; LATENT PERIOD; MALE; MOUSE; NERVE CONDUCTION; NERVE FIBER GROWTH; NEUROMODULATION; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PC12 CELL LINE; PERIPHERAL NEUROPATHY; TIEG1 GENE; TREATMENT RESPONSE; YAM;

DIOSCOREA; DIOSCOREA JAPONICA; DIOSCOREA NIPPONICA; MUS;

EID: 84908054767     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.051     Document Type: Article

References (44)

1. Anand, P., Terenghi, G., Warner, G., Kopelman, P., Williams-Chestnut, R. E. and Sinicropi, D. V. (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2, 703-707.
2. Apfel, S. C., Arezzo, J. C., Brownlee, M., Federoff, H. and Kessler, J. A. (1994) Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634, 7-12.
3. Boden, G. (2001) Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol. Metab. Clin. North Am. 30, 801-815, v.
4. Calcutt, N. A. (2004) Experimental models of painful diabetic neuropathy. J. Neurol. Sci. 220, 137-139.
5. Canta, A., Chiorazzi, A., Meregalli, C., Carozzi, V., Oggioni, N., Lauria, G., Lombardi, R., Bianchi, R., Porretta-Serapiglia, C. and Cavaletti, G. (2009) Continuous buprenorphine delivery effect in streptozotocine- induced painful diabetic neuropathy in rats. J. Pain 10, 961-968.
6. Choi, S. Z. and Son, M. W. (2011) Novel botanical drug for the treatment of diabetic neuropathy. Arch. Pharm. Res. 34, 865-867.
7. Gao, X., Li, B., Jiang, H., Liu, F., Xu, D. and Liu, Z. (2007) Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 78, 12-15.
8. Gerbitz, K. D., van den Ouweland, J. M., Maassen, J. A. and Jaksch, M. (1995) Mitochondrial diabetes mellitus: a review. Biochim. Biophys. Acta 1271, 253-260.
9. Hayes, A. G., Sheehan, M. J. and Tyers, M. B. (1987) Differential sensitivity of models of antinociception in the rat, mouse and guineapig to mu- and kappa-opioid receptor agonists. Br. J. Pharmacol. 91, 823-832.
10. Hellweg, R. and Hartung, H. D. (1990) Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26, 258-267.
11. Hellweg, R., Raivich, G., Hartung, H. D., Hock, C. and Kreutzberg, G. W. (1994) Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol. 130, 24-30.
12. Hikino, H., Konno, C., Takahashi, M., Murakami, M., Kato, Y., Karikura, M. and Hayashi, T. (1986) Isolation and hypoglycemic activity of dioscorans A, B, C, D, E, and F; glycans of Dioscorea japonica rhizophors. Planta Med. 168-171.
13. Hiransai, P., Ratanachaiyavong, S., Itharat, A., Graidist, P., Ruengrairatanaroj, P. and Purintrapiban, J. (2010) Dioscorealide B suppresses LPS-induced nitric oxide production and inflammatory cytokine expression in RAW 264.7 macrophages: The inhibition of NF-kappaB and ERK1/2 activation. J. Cell. Biochem. 109, 1057-1063.
14. Hsu, F. L., Lin, Y. H., Lee, M. H., Lin, C. L. and Hou, W. C. (2002) Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. J. Agric. Food Chem. 50, 6109-6113.
15. Jin, H. Y., Kim, S. H., Yu, H. M., Baek, H. S. and Park, T. S. (2013) Therapeutic potential of dioscorea extract (DA-9801) in comparison with alpha lipoic acid on the peripheral nerves in experimental diabetes. J. Diabetes Res. 2013, 631218.
16. Jung, S., Chung, J. S., Jang, S. M., Guh, J. O., Lee, H. J., Chon, S. U., Kim, K. M., Ha, S. B. and Back, K. (2003) Either soluble or plastidic expression of recombinant protoporphyrinogen oxidase modulates tetrapyrrole biosynthesis and photosynthetic efficiency in transgenic rice. Biosci. Biotechnol. Biochem. 67, 1472-1478.
17. Kakinoki, B., Sekimoto, S., Yuki, S., Ohgami, T., Sejima, M., Yamagami, K. and Saito, K. (2006) Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes 55, 616-621.
18. Kang, T. H., Moon, E., Hong, B. N., Choi, S. Z., Son, M., Park, J. H. and Kim, S. Y. (2011) Diosgenin from Dioscorea nipponica ameliorates diabetic neuropathy by inducing nerve growth factor. Biol. Pharm. Bull. 34, 1493-1498.
19. Kim, K. H., Kim, M. A., Moon, E., Kim, S. Y., Choi, S. Z., Son, M. W. and Lee, K. R. (2011a) Furostanol saponins from the rhizomes of Dioscorea japonica and their effects on NGF induction. Bioorg. Med. Chem. Lett. 21, 2075-2078.
20. Kim, M. W. (1998) Effect of H2O fraction of Dioscorea japonica Thunb. with selenium on plasma glucose and lipid metabolism in streptozotocin induced diabetic rats. Kor. J. Nutr. 31, 1377-1384.
21. Kim, N., Kim, S. H., Kim, Y. J., Kim, J. K., Nam, M. K., Rhim, H., Yoon, S. K., Choi, S. Z., Son, M., Kim, S. Y. and Kuh, H. J. (2011b) Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro. J. Ethnopharmacol. 137, 312-319.
22. Maithili, V., Dhanabal, S. P., Mahendran, S. and Vadivelan, R. (2011) Antidiabetic activity of ethanolic extract of tubers of Dioscorea alata in alloxan induced diabetic rats. Indian J. Pharmacol. 43, 455-459.
23. Mbiantcha, M., Kamanyi, A., Teponno, R. B., Tapondjou, A. L., Watcho, P. and Nguelefack, T. B. Analgesic and Anti-Inflammatory Properties of Extracts from the Bulbils of Dioscorea bulbifera L. var sativa (Dioscoreaceae) in Mice and Rats. Evid. Based Complement. Alternat. Med. 2011.
24. Nguelefack, T. B., Dutra, R. C., Paszcuk, A. F., Andrade, E. L., Tapondjou, L. A. and Calixto, J. B. (2010) Antinociceptive activities of the methanol extract of the bulbs of Dioscorea bulbifera L. var sativa in mice is dependent of NO-cGMP-ATP-sensitive-K(+) channel activation. J. Ethnopharmacol. 128, 567-574.
25. Obrosova, I. G. (2003) Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep. 3, 439-445.
26. Obrosova, I. G. (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6, 638-647.
27. Oh, P. S. and Lim, K. T. (2008) Plant glycoprotein modulates the expression of interleukin-1beta via inhibition of MAP kinase in HMC-1 cells. Biosci. Biotechnol. Biochem. 72, 2133-2140.
28. Ordonez, G., Fernandez, A., Perez, R. and Sotelo, J. (1994) Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J. Neurol. Sci. 121, 163-166.
29. Pearlstone, A. C., Oei, M. L. and Wu, T. C. (1992) The predictive value of a single, early human chorionic gonadotropin measurement and the influence of maternal age on pregnancy outcome in an infertile population. Fertil. Steril. 57, 302-304.
30. Pedicino, D., Liuzzo, G., Trotta, F., Giglio, A. F., Giubilato, S., Martini, F., Zaccardi, F., Scavone, G., Previtero, M., Massaro, G., Cialdella, P., Cardillo, M. T., Pitocco, D., Ghirlanda, G. and Crea, F. (2013) Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J. Diabetes Res. 2013, 184258.
31. Sima, A. A. and Sugimoto, K. (1999) Experimental diabetic neuropathy: an update. Diabetologia 42, 773-788.
32. Singh, U. and Jialal, I. (2008) Alpha-lipoic acid supplementation and diabetes. Nutr. Rev. 66, 646-657.
33. Spittau, G., Happel, N., Behrendt, M., Chao, T. I., Krieglstein, K. and Spittau, B. (2010) Tieg1/Klf10 is upregulated by NGF and attenuates cell cycle progression in the pheochromocytoma cell line PC12. J. Neurosci. Res. 88, 2017-2025.
34. Srinivasan, K. and Ramarao, P. (2007) Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125, 451-472.
35. Toth, C., Schmidt, A. M., Tuor, U. I., Francis, G., Foniok, T., Brussee, V., Kaur, J., Yan, S. F., Martinez, J. A., Barber, P. A., Buchan, A. and Zochodne, D. W. (2006) Diabetes, leukoencephalopathy and rage. Neurobiol. Dis. 23, 445-461.
36. Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355.
37. U.S. Food and Drug Administration (2009) Neurontin packaging insert. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm154552.htm. cited 2012 Aug 24.
38. van Dam, P. S. (2002) Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. 18, 176-184.
39. Vincent, A. M., Russell, J. W., Low, P. and Feldman, E. L. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25, 612-628.
40. Vinik, A. I., Park, T. S., Stansberry, K. B. and Pittenger, G. L. (2000) Diabetic neuropathies. Diabetologia 43, 957-973.
41. Vinik, A. I., Suwanwalaikorn, S., Stansberry, K. B., Holland, M. T., Mc- Nitt, P. M. and Colen, L. E. (1995) Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18, 574-584.
42. Wu, C. L., Lee, C. L. and Pan, T. M. (2009) Red mold dioscorea has a greater antihypertensive effect than traditional red mold rice in spontaneously hypertensive rats. J. Agric. Food Chem. 57, 5035-5041.
43. Xu, L. and Wang, W. (2002) Chinese materia media: Combinations & applications. Donica Publishing Ltd., Hertfordshire. UK.
44. Zorrilla Hernandez, E., Frati Munari, A., Lozano Castaneda, O., Villalpando Hernandez, S. and Boulton, A. J. (1994) [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment]. Gac. Med. Mex. 130, 18-25.